IDEAYA Biosciences Strengthens Management with Internal Appointments of Paul Stone J D as Chief Financial Officer Andres Ruiz Briseno C P A as Vice President Finance and Mick OQuigley M B A as Vice President Development Operations
Tuesday, July 9, 2019 BiopharmaWatch Research 1 min read
Key Takeaway: IDEAYA Biosciences Strengthens Management with Internal Appointments of Paul Stone J D as Chief Financial Officer Andres Ruiz Briseno C P A as Vice President Finance and Mick OQuigley M B A as Vice President Development Operations
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma
Full Press Release Details
IDEAYA Biosciences Strengthens Management with Internal Appointments of Paul Stone J D as Chief Financial Officer Andres Ruiz Briseno C P A as Vice President Finance and Mick OQuigley M B A as Vice President Development Operations.